Cargando…

Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study

BACKGROUND: Suspected nonischemic cardiomyopathy (NICM) is a common clinical setting with highly variable prognosis. Early noninvasive risk-stratification is important for justification of invasive examinations, specific treatment and patient surveillance. We studied the additional prognostic value...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pöyhönen, Pauli, Kivistö, Sari, Holmström, Miia, Hänninen, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153898/ https://www.ncbi.nlm.nih.gov/pubmed/25160650 http://dx.doi.org/10.1186/1471-2261-14-110

Ejemplares similares

Peak CK-MB has a strong association with chronic scar size and wall motion abnormalities after revascularized non-transmural myocardial infarction – a prospective CMR study
por: Pöyhönen, Pauli, et al.
Publicado: (2018)

Correlation between septal midwall late gadolinium enhancement on CMR and conduction delay on ECG in patients with nonischemic dilated cardiomyopathy
por: Becker, Marthe A.J., et al.
Publicado: (2020)

Partial anomalous pulmonary venous return and atrial septal defect in adult patients detected with 128-slice multidetector computed tomography
por: Kivistö, Sari, et al.
Publicado: (2011)

Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy
por: Holmström, Miia, et al.
Publicado: (2011)

Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations
por: Pöyhönen, Pauli, et al.
Publicado: (2015)

Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement
por: Villa, Adriana, et al.
Publicado: (2014)

Late-Gadolinium Enhancement Interface Area and Electrophysiological Simulations Predict Arrhythmic Events in Patients With Nonischemic Dilated Cardiomyopathy
por: Balaban, Gabriel, et al.
Publicado: (2021)

Description of A/C gene mutation related dilated cardiomyopathy with gadolinium- enhanced magnetic resonance imaging
por: Holmström, Miia, et al.
Publicado: (2011)

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
por: Roussin, Isabelle, et al.
Publicado: (2013)

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
por: Roussin, Isabelle, et al.
Publicado: (2009)

Prognostic significance of the extent of septal fibrosis quantified on late gadolium enhanced images in patients with nonischemic cardiomyopathy
por: Cornhill, Aidan K, et al.
Publicado: (2015)

Additive prognostic value of red cell distribution width over late gadolinium enhancement on CMR in patients with non-ischemic dilated cardiomyopathy
por: Yi, Jeong-Eun, et al.
Publicado: (2020)

Impact of late gadolinium-enhanced cardiac MRI on arrhythmic and mortality outcomes in nonischemic dilated cardiomyopathy: updated systematic review and meta-analysis
por: Theerasuwipakorn, Nonthikorn, et al.
Publicado: (2023)

CMR - Late gadolinium enhancement characteristics associated with monomorphic ventricular arrhythmia in patients with non-ischemic cardiomyopathy
por: Rajinthan, Priyanka, et al.
Publicado: (2022)

Biventricular thrombi of nonischemic cardiomyopathy
por: Adnan, Mohammed Muqeet, et al.
Publicado: (2014)

Ventricular arrhythmias in nonischemic cardiomyopathy
por: Chung, Fa‐Po, et al.
Publicado: (2018)

Sibutramine-Induced Nonischemic Cardiomyopathy
por: Shah, Meet S, et al.
Publicado: (2022)

Comparison of electroanatomic voltage mapping with late gadolinium enhancement CMR
por: Peters, Dana C, et al.
Publicado: (2014)

Hypertrophic cardiomyopathy and fibrosis: correlation between late gadolinium enhancement on CMR and speckle tracking imaging using Ultrasound
por: Cautela, Jennifer, et al.
Publicado: (2015)

Correlation of myocardial strain by CMR-feature tracking with substrate abnormalities detected by electro-anatomical mapping in patients with nonischemic cardiomyopathy
por: Raja, Deep Chandh, et al.
Publicado: (2023)

Ventricular arrhythmias in nonischemic cardiomyopathy: Overview
por: Kusano, Kengo
Publicado: (2018)

Association of late gadolinium enhancement in cardiac magnetic resonance with mortality, ventricular arrhythmias, and heart failure in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis
por: Al-Sadawi, Mohammed, et al.
Publicado: (2023)

Stratification of the Risk of Sudden Death in Nonischemic Heart Failure
por: Pimentel, Maurício, et al.
Publicado: (2014)

Late gadolinium enhancement is compatible with advanced age in hypertrophic cardiomyopathy: implications for risk stratification of sudden death
por: Chan, Raymond H, et al.
Publicado: (2012)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013)

Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
por: Doesch, Christina, et al.
Publicado: (2017)

Association of Whole-Heart Myocardial Mechanics by Transthoracic Echocardiography with Presence of Late Gadolinium Enhancement by CMR in Non-Ischemic Dilated Cardiomyopathy
por: Mėlinytė-Ankudavičė, Karolina, et al.
Publicado: (2022)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy
por: Okubo, Kenji, et al.
Publicado: (2018)

Bevacizumab: A Rare Cause of Nonischemic Cardiomyopathy
por: Oladiran, Oreoluwa, et al.
Publicado: (2018)

Prognostic significance of ventricular function and late gadolinium enhancement on CMR in symptomatic patients with scleroderma
por: Natarajan, Arun, et al.
Publicado: (2013)

Exclusion of prognostic coronary disease in LV dysfunction using late gadolinium enhancement CMR
por: Thompson, Alexandra, et al.
Publicado: (2015)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Cardiomyocyte Regeneration in the mdx Mouse Model of Nonischemic Cardiomyopathy
por: Richardson, Gavin David, et al.
Publicado: (2015)

Added value of contrast echocardiography in characterization of nonischemic cardiomyopathy
por: Pi, Shufang, et al.
Publicado: (2018)

A Rare Case of Phentermine-Induced Nonischemic Cardiomyopathy
por: Damani, Devanshi, et al.
Publicado: (2022)

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2010)

Exuberant Pattern of Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
por: Fernandes, Elsa, et al.
Publicado: (2013)

Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
por: Aquaro, Giovanni Donato, et al.
Publicado: (2023)

Late gadolinium enhancement (LGE) progresses with right ventricle volume in children after repair of tetralogy of fallot()
por: Ylitalo, Pekka, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4jtbdeg0ahgktcnvv2u7ck23j7